Related Experiment Video
Updated: Aug 8, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
Hexachlorophene inhibits Wnt/beta-catenin pathway by promoting Siah-mediated beta-catenin degradation
Seoyoung Park1, Jungsug Gwak, Munju Cho
1PharmcoGenomics Research Center, Inje University, Busan 614-735, Korea.
Abstract:
Aberrant activation of Wnt/beta-catenin signaling and subsequent up-regulation of beta-catenin response transcription (CRT) is a critical event in the development of human colon cancer. Thus, Wnt/beta-catenin signaling is an attractive target for the development of anticancer therapeutics. In this study, we identified hexachlorophene as an inhibitor of Wnt/beta-catenin signaling from cell-based small-molecule screening. Hexachlorophene antagonized CRT that was stimulated by Wnt3a-conditioned medium by promoting the degradation of beta-catenin. This degradation pathway is Siah-1 and adenomatous polyposis colidependent, but glycogen synthase kinase-3beta and F-box beta-transducin repeat-containing protein-independent. In addition, hexachlorophene represses the expression of cyclin D1, which is a known beta-catenin target gene, and inhibits the growth of colon cancer cells. Our findings suggest that hexachlorophene attenuates Wnt/beta-catenin signaling through the Siah-1-mediated beta-catenin degradation.
Insights
Hexachlorophene inhibits colon cancer growth by targeting Wnt/beta-catenin signaling. This compound promotes beta-catenin degradation, repressing cancer cell proliferation and offering a potential therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Aberrant Wnt/beta-catenin signaling and beta-catenin response transcription (CRT) are key drivers of human colon cancer.
- Targeting Wnt/beta-catenin signaling presents a promising avenue for developing novel anticancer therapeutics.
Purpose of the Study:
- To identify small molecules that inhibit Wnt/beta-catenin signaling.
- To investigate the mechanism of action of identified inhibitors in colon cancer cells.
Main Methods:
- Cell-based small-molecule screening to identify Wnt/beta-catenin signaling inhibitors.
- Wnt3a-conditioned medium stimulation to assess CRT antagonism.
- Analysis of beta-catenin degradation pathways, including Siah-1 and adenomatous polyposis coli (APC) dependence.
- Evaluation of cyclin D1 expression and colon cancer cell growth inhibition.
Main Results:
- Hexachlorophene was identified as a novel inhibitor of Wnt/beta-catenin signaling.
- Hexachlorophene antagonized Wnt3a-stimulated CRT by promoting beta-catenin degradation.
- Beta-catenin degradation was dependent on Siah-1 and APC, but independent of GSK-3beta and F-box proteins.
- Hexachlorophene repressed cyclin D1 expression and inhibited colon cancer cell growth.
Conclusions:
- Hexachlorophene effectively attenuates Wnt/beta-catenin signaling in colon cancer.
- The mechanism involves Siah-1-mediated beta-catenin degradation.
- Hexachlorophene demonstrates potential as an anticancer therapeutic agent for colon cancer.
More Related Videos
Related Concept Videos
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Hedgehog Signaling Pathway
Anaphase Promoting Complex
Inhibition of Cdk Activity
